Search for: "R-R Drugs, Inc."
Results 41 - 60
of 5,177
Sorted by Relevance
|
Sort by Date
25 Apr 2017, 8:43 pm
Amgen Inc, involving interpretation for the first time of the Biologics Price Competition and Innovation Act ("BPCIA"), which was enacted in 2010 to facilitate the entry of biosimilar drug products into the marketplace. [read post]
29 Aug 2011, 12:30 pm
By Kurt R. [read post]
Parmaceutical Companies pay over $400 million to settle allegations of price fixing of generic drugs
1 Oct 2021, 9:28 am
Americans have the right to purchase generic drugs set by fair and open competition, not collusion,” said Special Agent in Charge Maureen R. [read post]
24 Jan 2011, 3:15 pm
By Kurt R. [read post]
14 Dec 2017, 9:11 pm
Amgen Inc., the Supreme Court handed down its interpretation of the Biologics Price Competition and Innovation Act ("BPCIA") for the approval of biosimilar drugs. [read post]
30 Mar 2011, 5:32 pm
By Kurt R. [read post]
10 Jan 2014, 2:14 pm
He apparently denied ownership of the second gun, an H&R Inc. [read post]
24 Apr 2017, 9:59 pm
Amgen Inc. case. [read post]
5 Nov 2021, 5:21 pm
Americans have the right to purchase generic drugs set by fair and open competition, not collusion,” said Special Agent in Charge Maureen R. [read post]
11 Feb 2015, 4:45 pm
The family of sisters Ryeley Beatty, 3, and Brooklyn, 2, are suing Babies R Us and Baby Cache Inc. for wrongful death. [read post]
15 Jan 2014, 5:43 am
David R. [read post]
22 Mar 2020, 8:02 pm
Timothy R. [read post]
20 Mar 2012, 9:22 pm
Prometheus Laboratories, Inc. [read post]
20 Feb 2009, 9:25 am
Judge Charles R. [read post]
25 May 2010, 12:51 pm
By Kurt R. [read post]
8 Jul 2011, 1:13 pm
In 2009, Reckitt Benckiser Inc. sued Watson Laboratories, Inc. - Florida for patent infringement related to Watson's filing of three Abbreviated New Drug Applications for generic versions of Reckitt's Mucinex(R) line of products. [read post]
25 Aug 2009, 1:12 pm
Gilead Sciences Inc. [read post]
8 Aug 2012, 8:40 pm
By Kurt R. [read post]
29 Jun 2010, 6:09 am
The Food and Drug Administration said Monday Pfizer Inc. is withdrawing its cancer drug Mylotarg from the U.S. market after a clinical study showed the drug wasn't effective and had more safety problems. [read post]
8 Mar 2017, 9:59 pm
By Donald Zuhn -- Last month, in In re Depomed, Inc., the Federal Circuit affirmed the determination by the U.S. [read post]